PainReform (PRFX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PainReform Ltd. has appointed Eyal Broder as the Interim Chief Financial Officer, succeeding Dr. Ehud Geller, who remains the Executive Chairman and Interim CEO. The company regained compliance with Nasdaq’s minimum bid price requirement after a period of non-compliance. These changes could influence investor confidence as PainReform navigates its financial and operational strategies.
For further insights into PRFX stock, check out TipRanks’ Stock Analysis page.
